Benjamin Petsch

Paul Ehrlich Str. 15
Tuebingen, BW 72076, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Seasonal influenza mRNA vaccine induces stronger innate and comparable or better adaptive responses than licensed inactivated vaccines.

Seasonal influenza mRNA vaccine induces stronger innate and comparable or better adaptive responses than licensed inactivated vaccines.

Journal: NPJ vaccines

Published: January 05, 2026

Boosting SIV-specific CD8+ T cell responses prior to ART interruption extends time to SIVmac239 rebound.

Boosting SIV-specific CD8+ T cell responses prior to ART interruption extends time to SIVmac239 rebound.

Journal: The Journal of clinical investigation

Published: July 22, 2025

An mRNA-based FimH nanoparticle vaccine against uropathogenic Escherichia coli is highly immunogenic in rodents.

An mRNA-based FimH nanoparticle vaccine against uropathogenic Escherichia coli is highly immunogenic in rodents.

Journal: Frontiers in immunology

Published: July 18, 2025

Retraction: Aerosols Transmit Prions to Immunocompetent and Immunodeficient Mice.

Retraction: Aerosols Transmit Prions to Immunocompetent and Immunodeficient Mice.

Journal: PLoS pathogens

Published: July 18, 2024

mRNA vaccine-induced IgG mediates nasal SARS-CoV-2 clearance in mice.

mRNA vaccine-induced IgG mediates nasal SARS-CoV-2 clearance in mice.

Journal: Molecular therapy. Nucleic acids

Published: June 28, 2024

mRNA-Based Vaccines Are Highly Immunogenic and Confer Protection in the Gnotobiotic Pig Model of Human Rotavirus Diarrhea.

mRNA-Based Vaccines Are Highly Immunogenic and Confer Protection in the Gnotobiotic Pig Model of Human Rotavirus Diarrhea.

Journal: Vaccines

Published: January 16, 2024

mRNA vaccines expressing malaria transmission-blocking antigens Pfs25 and Pfs230D1 induce a functional immune response.

mRNA vaccines expressing malaria transmission-blocking antigens Pfs25 and Pfs230D1 induce a functional immune response.

Journal: NPJ vaccines

Published: August 04, 2023

Author Correction: Unmodified rabies mRNA vaccine elicits high cross-neutralizing antibody titers and diverse B cell memory responses.

Author Correction: Unmodified rabies mRNA vaccine elicits high cross-neutralizing antibody titers and diverse B cell memory responses.

Journal: Nature communications

Published: July 10, 2023

mRNA-based VP8* nanoparticle vaccines against rotavirus are highly immunogenic in rodents.

mRNA-based VP8* nanoparticle vaccines against rotavirus are highly immunogenic in rodents.

Journal: NPJ vaccines

Published: March 31, 2023

Assessment of Immunogenicity and Efficacy of CV0501 mRNA-Based Omicron COVID-19 Vaccination in Small Animal Models.

Assessment of Immunogenicity and Efficacy of CV0501 mRNA-Based Omicron COVID-19 Vaccination in Small Animal Models.

Journal: Vaccines

Published: January 04, 2023

SARS-CoV-2 variants of concern elicit divergent early immune responses in hACE2 transgenic mice.

SARS-CoV-2 variants of concern elicit divergent early immune responses in hACE2 transgenic mice.

Journal: European journal of immunology

Published: December 13, 2022

A third dose of the unmodified COVID-19 mRNA vaccine CVnCoV enhances quality and quantity of immune responses.

A third dose of the unmodified COVID-19 mRNA vaccine CVnCoV enhances quality and quantity of immune responses.

Journal: Molecular therapy. Methods & clinical development

Published: August 04, 2022

Showing 1-12 of 37

Last Updated: 09/26/2026